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Summary 
Anaemia increases with age and is common among older people.  Due to its relationship 
with morbidity and mortality, accurate diagnosis is important. Thresholds defining the 
diagnosis of anaemia have been the subject of considerable scientific debate, with both 
higher and lower cut-offs proposed. High haemoglobin is also a health risk in some but 
not all studies. Using nationally representative data of 5,329 adults aged 65+ (Health 
Survey for England 1998, 2005, 2006), linked to administrative mortality data, this paper 
describes the relationship between haemoglobin levels and mortality, adjusted for age 
and other confounders.  Among men, a reverse J shaped relationship was observed: 
relative to the modal group (14– 14.9g/dl), those with ‘mild anaemia’ of 12–12.9g/dl 
haemoglobin had a 56% (95% CI 24%-96%) greater mortality hazard, and those with 
‘severe anaemia’, haemoglobin <12g/dl, had an 87% (39%-153%) greater hazard.  At 
the other end of the range, those with haemoglobin of ≥16g/dl had 32% (2%-70%) 
greater mortality hazard.  Haemoglobin levels in women showed a similar but smaller, 
non-significant pattern: hazard ratio 1.32 (0.91-1.92) for severe anaemia (<11g/dl), and 
1.30 (0.95-1.79) for high haemoglobin (≥15g/dl).  This research supports the use of the 
WHO thresholds (13g/dl for men, 12g/dl for women).  
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Introduction 
 
Anaemia is a common problem, particularly among older people (aged 65 and over) 
(Beghe et al, 2004; Guralnik et al, 2004; Craig et al, 2007).  Although the underlying 
cause is not identified in up to one in three cases (Penninx et al, 2006; Tettamanti et al, 
2010), many diseases and conditions are associated with anaemia, including cancer, 
chronic kidney disease, chronic inflammation, congestive heart failure, iron deficiency 
and other nutritional deficiencies, bone marrow failure and malnutrition (Penninx et al, 
2006). Anaemia is also associated with depression (Onder et al, 2005). The cause of 
anaemia may affect haemoglobin concentration, with most studies finding that 
haemoglobin concentrations are lowest in those with iron deficiency anaemia, closest to 
normal in anaemia of inflammation, with unexplained anaemia in between (Merchang et 
al, 2012).  
 
Regardless of cause, individuals with anaemia have increased mortality (Chaves et al, 
2004; Zakai et al, 2005; Culleton et al, 2006; Bross et al, 2010) and morbidity, including 
hospitalization (Penninx et al, 2006; Culleton et al, 2006), physical disability (Maraldi et 
al, 2006), poor physical function and falls (Penninx et al, 2005), and fracture incidence 
(Chen et al, 2010), and more rapid decline in cognitive function (Shah et al, 2011).  
Anaemia affects disease-related mortality, morbidity and quality of life (Spivak et al, 
2005; Zakai et al 2005), independently of prevalent diseases at baseline (Penninx et al, 
2005; Penninx et al, 2006; Shah et al, 2011), though some associations are due 
primarily to comorbidity (Maraldi et al, 2006). 
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However, a several studies have criticized the use of the World Health Organization 
(WHO) criteria (<13g/dl [<8.1mmol/l] haemoglobin for men, <12g/dl [<7.5mmol/l] 
haemoglobin for women) for older adults (Isaks et al, 1999; Patel et al, 2009). These 
criteria were developed in 1968, based on statistical distributions equivalent to two 
standard deviations below the mean in a reference sample aged <65 years.  Thresholds 
defining anaemia in older populations have been the subject of considerable scientific 
debate. Some studies used lower, non-sex specific, thresholds for anaemia among the 
elderly, including <11g/dl (Culleton et al 2006) and <11.5g/dl (Joosten et al 1992). Riva 
et al (2009) used <10.0 g/dl to differentiate “Severe anaemia”, from “Mild anaemia” 
(>=10 but under the WHO limits).  Others have used higher, sex specific thresholds: 
0.2g/dl above WHO limits (Beutler and Waalen 2006); and 0.1-2.0g/dl above WHO 
limits, i.e. “low-normal haemoglobin” (Penninx et al, 2006; Chaves et al, 2002). 
Additionally, three studies in older adults have shown elevated mortality amongst those 
in the highest and in the lowest quintiles of haemoglobin levels, (Zakai et al, 2005; 
Culleton et al, 2006), even after extensive adjustment for other factors (Dharmarajan et 
al, 2005).   
 
This paper investigates which haemoglobin levels are associated with all-cause mortality 
in adults in the general population and examined the effects of different haemoglobin 
levels on mortality, to contribute to the debate on the thresholds for harmful haemoglobin 
levels in older people. 
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Materials and Methods 
Participants 
The Health Survey for England (HSE) is an annual, cross-sectional survey of a nationally 
representative sample of adults and children living in private households in England 
(Mindell et al, 2012).  Each year, core modules of questions and measurements are 
supplemented by population boosts and/or or additional topics.  In 1998 and 2006,  
modules were included on cardiovascular disease and physical activity; in 2005, the 
HSE focused on the health, risk factors, and determinants of health of people aged 65+ 
(Erens et al, 2000; Craig et al, 2007; Craig et al, 2008).  
 
Data collection 
The sampling design and method have been described in detail elsewhere (Erens et al, 
2000; Craig et al, 2007; Craig et al, 2008).  A random sample was selected each year 
using a two-stage, stratified process.  After sending a letter, an interviewer visited the 
address to recruit the participants and conduct the interviews, using computer-assisted 
personal interviewing (CAPI). 
 
Household-level socio-demographic data included equivalised household income 
(income adjusted for the number of adults and children in the household).  Individual-
level socio-demographic data (occupational social class and years of education) were 
supplemented by questions about general self-reported health, smoking, (other health 
behaviours had been measured in non-comparable ways in different survey years), and 
doctor-diagnosed cardiovascular conditions (CVD, namely stroke, myocardial infarction, 
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angina, dysrhythmia, heart murmur or other heart condition, not asked of half the sample 
aged 65+ in 2006). 
 
Participants were also asked whether they had “any longstanding illness, disability or 
infirmity”.  Those who replied ‘yes’ were asked whether this had limited their daily 
activities or the work that they could do in any way.  The interviewer also measured 
height and weight.  After the interviewer visit, non-fasting blood samples were obtained 
from consenting adults during a nurse visit. For participants who gave consent for their 
data to be linked to NHS records, their identifying information was sent to the NHS, to be 
flagged as an HSE participant. The mortality data for all flagged respondents was 
extracted in January 2011, stating for each person whether or not they had died, and if 
so, when. 
 
Blood samples were posted to the Department of Clinical Biochemistry at the Royal 
Victoria Infirmary, Newcastle for analysis.  Haemoglobin was measured on Abbott 
Diagnostics Cell-Dyn 4000 analysers.  Further details of laboratory measurements and 
of quality control are available elsewhere (Erens et al, 2000; Craig et al, 2007; Craig et 
al, 2008).  
 
Ethical approval  
Ethical approval for the three surveys was obtained from the London Multi-centre 
Research Ethics Committee (MREC) prior to the surveys.  All participants gave oral 
consent to be interviewed and have measurements made, and written consent to have 
blood samples taken and mortality data linked to the survey data. 
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Statistical analysis 
Analyses in this paper include participants aged 65+ from HSE 1998, 2005 and 2006, 
who had given consent for their data to be linked to mortality data, and had provided a 
valid haemoglobin sample (Table 1).  Haemoglobin levels vary by race/ethnicity and the 
impact on mortality of a given level may also vary (Denny et al 2006; Patel et al 2007; 
Dong et al 2008; Patel et al 2009). As numbers from non-white groups were too small for 
separate analysis (1.5% were non-white), this paper is restricted to data from people of a 
white ethnic background.  Overall, 51% of those interviewed who were included in the 
analysis.   
 
Haemoglobin results were grouped in two ways:  by sex-specific quintile, and by bands 
defined by 1g/dl relative to the WHO criteria for each sex (haemoglobin <13g/dl 
[<8.1mmol/l] in men and <12g/dl [<7.5mmol/l] in women).  People taking iron or other 
hematinics were also excluded from these analyses. With the data available, it was not 
possible to distinguish the cause of anaemia, therefore only haemoglobin results were 
used for the categorization.  
 
Non-response weighting was introduced to HSE in 2003, as with other UK government 
surveys, because of falling response rates. Variables enabling adjustment for complex 
survey design were also introduced at that time.  Except when describing participants’ 
characteristics (Table 2), the data were weighted for non-response to the blood sample, 
so that although some groups tended to be over or under-represented in a, the survey 
and b, the blood sample, this was corrected in the analysis (using weights provided for 
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2005 and 2006, and a weight of 1 for the 1998 sample), and the complex survey design 
accounted for in the analysis: data from 1998 were ascribed dummy variables for strata 
and sampling point. 
 
Survival analysis was carried out using STATA version 12 to estimate the hazard of 
death in the substantially censored data (by the end of follow-up, 5-13 years post-
interview, 72% of the sample were censored, i.e. still alive). Cox’s regression was used 
to estimate the hazard ratio of time to death post-interview for each quintile of 
haemoglobin relative to the middle quintile and also for each 1g/dl group relative to the 
modal group whilst controlling for other significant factors.  Preliminary analysis showed 
marked sex differences, so analyses were conducted separately by sex.  All analyses 
were adjusted for age using five-year age groups to 85+. 
 
Socio-economic factors (education, income, and social class), smoking, BMI, 
longstanding illness, and self-reported doctor-diagnosed CVD were assessed in 
univariate analyses then significant variables considered in multivariate Cox regression.  
Age at leaving full-time education explained more of the variation in outcome than other 
socio-economic factors.  CVD was not significant when longstanding illness, age and 
haemoglobin group were included; and since longstanding illness was available for the 
full sample, but CVD asked only of half the 2006 sample, CVD was not included in the 
final models.  Kaplan-Meier survival curves were prepared comparing participants in the 
different haemoglobin bands.  Adjacent, central bands with similar hazard ratios were 
combined to limit the number of curves displayed (see Figure 2). 
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Results  
Response rates by survey year and sex are provided in Table 1. Among the sample 
available for survival analysis, 2446 men and 2863 women aged 65+ provided usable 
blood samples. Participant characteristics (unweighted and without adjustment for 
complex survey design) are presented in Table 2. The prevalence of anaemia (weighted 
for non-response) was 14% for men and 11% for women, including 5% of men and 3% 
of women with haemoglobin more than 1g/dl below WHO thresholds.  Anaemia 
prevalence increased with age, from 6% of men aged 65-69, to 31% of those aged 85+, 
and from 5% to 22% of women. High haemoglobin levels (haemoglobin ≥ 3g/dl above 
the WHO anaemia threshold) decreased with age, from 13% to 6% among men, and 9% 
to 4% among women. The modal haemoglobin band was 1-2g/dl above the WHO 
threshold for both sexes (mean 14.4g/dl in men, 13.4g/dl in women).   
 
Figure 1, panels A and B, show hazard ratios for time to death by quintile of 
haemoglobin level, adjusted for other significant factors. For men, only the lowest 
quintile differed significantly from the middle quintile. For women, no quintile was 
significantly different from the middle quintile. As categorization by haemoglobin band 
appears to be more discriminating (panels C and D), the rest of this paper focuses on 
the haemoglobin bands. 
 
When adjusted only for age, the highest hazard ratio among men was for the lowest 
haemoglobin group, <12 g/dl (HR 2.19, 95%CI 1.66–2.90). Mild anaemia (haemoglobin 
12.0-12.9 g/dl) was also a significant risk (1.64, 1.31–2.06), as was high haemoglobin (≥ 
16g/dl, HR 1.35, 1.04–1.74). For women, only those with more severe anaemia (<11g/dl) 
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had a significant risk (age-adjusted HR. 1.61, 1.08–2.41). Unlike men, neither women 
with mild anaemia (11.0-11.9 g/dl) nor with high haemoglobin (≥ 15g/dl) had significantly 
raised hazard ratios (p=0.06 in both cases), but the sample sizes and number of deaths 
among these groups were smaller for women than men. 
 
When additional variables were added to the model, lower education, current or previous 
smoking, having a limiting longstanding illness, and being underweight were also 
associated with mortality (being overweight was associated with survival among women 
only). After adjustment for these factors, the significance and magnitude of the risk 
posed by high or low haemoglobin fell slightly for both men and women, but remained 
significant for men. For men, the highest hazard ratio remained for those with more 
severe anaemia, <11g/dl (HR 1.87, CI 1.39–2.53).  Mild anaemia (haemoglobin 11.0-
11.9g/dl) was also a significant risk (1.56, 1.24–1.96), as was high haemoglobin (≥ 
16g/dl (1.32 1.02–1.70, Figure 1C).  For women, after adjustment for multiple factors, no 
haemoglobin band showed significant difference from the reference group, although a 
non-significant U-shaped association was seen (Figure 1D). 
 
Kaplan-Meier curves showed that survival was worst for men with more severe anaemia 
but was also worse for those with mild anaemia or high haemoglobin, compared with 
those whose baseline haemoglobin was 0-3g/dl above the WHO thresholds (Figure 2A). 
For women, no significant differences were seen (Figure 2B).  
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Discussion 
Anaemia is of concern because of the morbidity and mortality associated both with the 
abnormally low haemoglobin level and with the underlying cause(s) of the anaemia, a 
condition which is common and increases with age (Beghe et al 2004; Guralnik et al 
2004; Craig et al 2007). As the population ages and the prevalence of anaemia 
increases, an understanding of these associations is essential. We have shown that for 
men, both mild and more severe anaemia were significantly associated with reduced 
survival, compared with normal haemoglobin, defined using WHO thresholds. The group 
with the highest levels of haemoglobin (≥ 16g/dl) also had a significantly raised adjusted 
hazard ratio. It is unclear whether any U shaped or reverse J shaped effect on mortality 
operates through the same causal pathways at both high and low values. Although 
anaemia was significantly associated with mortality only in men among these HSE 
participants, a similar relationship was seen in women but the 95% confidence intervals 
were wide.  
 
Greater detail about the relationship between haemoglobin level and mortality hazard 
can be seen using haemoglobin bands than quintiles. This is probably because the 
lowest and highest quintiles each included people with normal haemoglobin levels, 
which we have shown was not associated with mortality in our study. 
 
Although the presence of ‘low normal’ haemoglobin levels has previously been 
associated with increased morbidity and mortality (Zakai et al 2005; Penninx et al 2006), 
there was no association between survival and ‘low normal’ haemoglobin in HSE 
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participants.  Our study provides reassurance that the current WHO thresholds are 
neither too low, unlike some studies’ conclusions (Zakai et al 2005; Patel et al 2009), nor 
too high, as proposed by others (Joosten et al 1992; Isaks et al 1999; Culleton et al 
2006; Patel et al 2009).  
 
The main strengths of the study are that it includes a large nationally-representative 
sample, rather than being a local population or one collected through use of healthcare 
services.  The study includes the use of standardised methods for ascertaining 
haemoglobin status and relevant confounding factors. It is only the second study to 
examine a nationally-representative sample of free-living older people. 
 
One limitation of this paper is that people living in institutions were excluded.  This group 
has lower haemoglobin levels and a higher prevalence of anaemia (Bajekal 2002) than 
the general population but their prevalence of ‘low normal’ haemoglobin has not been 
investigated.  In HSE 2000, blood samples were obtained from 627 residents of care 
homes. Overall, 38% of men and 30% of women had anaemia (using WHO criteria), 
while 24% and 25% respectively had ‘low normal’ haemoglobin.  The prevalence of ‘low 
normal’ haemoglobin is not markedly different, although anaemia was far more common 
in residents of care homes.  However, the care home residents in HSE 2000 were much 
older: 44% of men and 60% of women aged 65+ living in care homes who provided 
blood samples in HSE 200 were aged 85+, compared with 7% and 8% of men and 
women aged 65+ in HSE 2005. Also, no information was available on other related 
nutritional deficiency states, dietary intakes or on dosage of iron in multivitamin 
supplements. 
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Longstanding illness was chosen as an explanatory variable for survival rather than self-
reported health to avoid reverse causality of poor subjective health due to anaemia.  
When factors associated with reduced survival were added into the model, education, 
smoking, BMI, and longstanding illness were each associated with survival; their 
inclusion reduced the effect of more severe anaemia in men by 20%, from HR 2.19 to 
1.87 (20% is the difference between log 2.19 and log 1.87). The addition of these factors 
reduced the effect of ‘mild’ anaemia by 11% and the effect of high haemoglobin by 2%. 
No serum creatinine data were available, so we were unable to adjust for chronic kidney 
disease, which would affect both mortality and haemoglobin levels. 
 
Although only half the participants aged 65 and over in HSE 2005 gave a blood sample, 
results were weighted to adjust for known characteristics that differed between 
participants in the interview who did and did not give a blood sample, in addition to the 
basic non-response weighting.   There was no attempt to weight for non-consent to data 
linkage. However, among those giving a blood sample, the consent rate was very high 
(92%), so this is unlikely to a major source of response bias.  
 
Numbers were too small to investigate whether using the lower Joostens criteria to 
define anaemia in older people identified a group at higher risk, however given the sex 
differences found in our analysis, this supports the use of sex-specific thresholds.   
 
Another limitation was that there were too few participants from non-white ethnic groups 
to examine ethnic differences in this relationship. The prevalence of anaemia, defined by 
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WHO criteria, is higher in African Americans than Caucasians (Denny et al 2006, Dong 
et al 2008).  In some studies, the age-adjusted mortality risk ratio did not differ by sex or 
race, using the WHO criteria, (Denny et al 2006, Dong et al 2008) but others found that 
WHO-defined anaemia was associated with mortality only in white not black adults aged 
71-82y; mortality rates in black men were higher only in those whose haemoglobin was 
below 2g/dl below the WHO threshold (i.e. <11.0g/dl) (Patel et al 2007). Significantly 
raised mortality hazard ratio was found in whites but not blacks with ‘low normal’ 
haemoglobin (Dong et al 2008).  The NHANES III data found that mortality was raised 
below race-specific thresholds of 0.2g/dl above the WHO thresholds in Mexican 
Americans, and 0.7g/dl below the threshold in non-Hispanic blacks (Patel et al 2009).  
 
Unlike previous reports, our study does not support screening to identify older individuals 
with ‘low normal’ haemoglobin.  We have confirmed the adverse effect of anaemia and 
also of high haemoglobin in men on survival, independently of other major risk factors, 
but did not find any such effect in women. Further studies or longer follow-up of the HSE 
participants will be required to assess whether this is a problem of low numbers and 
therefore limited power to confirm the association, or whether there are other 
explanations, such as differential association between mortality and only some types of 
anaemia (Semba et al 2007). 
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Table 1 Response to haemoglobin sample and data linkage, by survey year 
 
n % of 
interviewed 
% of eligible 
for blood 
sample 
1998    
Household response rate to interview  74%   
Individual response rate (within cooperating  
households) 
97%   
Interviewed 3199   
Consented to mortality data & data able to be matched 2634 82  
Agreed nurse visit 2888 90  
Nurse visit completed 2702 84  
Eligible for haemoglobin blood sample 2505   
Agreed blood sample 2277 71 91 
Valid haemoglobin result obtained 2089 65 83 
Mortality records matched and valid haemoglobin 
result 
2048 64 82 
2005    
Household response rate to interview  71%   
Individual response rate (within cooperating  
households) 
97%   
Interviewed 4118   
Consented to mortality data & data able to be matched 2642 64  
Agreed nurse visit 3392 82  
Nurse visit completed 3070 75  
Eligible for haemoglobin blood sample 2772   
Agreed blood sample 2393 58 86 
Valid haemoglobin result obtained 2107 51 76 
Mortality records matched and valid haemoglobin 
result 
1839 45 66 
2006    
Household response rate to interview  68%   
Individual response rate (within cooperating  
households) 
96%   
Interviewed 3175   
Consented to mortality data & data able to be matched 2518 79  
Agreed nurse visit 2599 82  
Nurse visit completed 2381 75  
Eligible for haemoglobin blood sample 2112   
Agreed blood sample 1815 57 86 
Valid haemoglobin result obtained 1607 51 76 
Mortality records matched and valid haemoglobin 
result 
1442 45 68 
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Table 2 Participant Characteristics  
 
 Men Women  
 1998 2005 2006 Total 1998 2005 2006 Total 
N included in analysis 947 855 664 2,466 1,101 984 778 2,863 
 % % % % % % % % 
Haemoglobin 
More than 1g/dl below WHO limit a 5 4 4 5 4 2 2 3 
0.1 - 1g/dl below WHO limit 10 7 7 8 8 8 6 7 
Anaemia (WHO criteria)a 16 11 11 13 11 10 8 10 
0 - 0.9g/dl above WHO limit 19 19 20 19 25 21 19 22 
1 - 1.9g/dl above WHO limit 33 29 30 31 36 37 39 37 
2 - 2.9g/dl above WHO limit 24 28 27 26 22 24 25 24 
3g/dl or more above WHO limit 9 14 11 11 6 8 8 7 
Lowest quintile 23 19 19 21 23 19 17 20 
2nd quintile 22 19 20 20 24 22 21 22 
3rd quintile 23 21 23 22 18 18 20 19 
4th quintile 17 20 19 19 18 21 22 20 
Highest quintile 16 21 19 18 17 20 20 19 
Age         
65-69 35 35 35 35 30 31 36 32 
70-74 26 28 30 28 24 29 25 26 
75-79 20 21 18 20 24 19 19 21 
80-84 12 10 12 12 14 13 12 13 
85+ 7 6 5 6 8 8 8 8 
mean age 73.4 73.2 73.1 73.3 74.3 73.9 73.5 73.9 
s.e. mean 0.21 0.22 0.24 0.13 0.20 0.21 0.24 0.12 
Longstanding illness         
None 34 31 30 32 33 31 31 32 
Non-limiting  23 32 31 28 23 27 27 25 
Limiting  43 37 39 40 45 42 42 43 
BMI         
Normal (18.5 - 24.9kg/m2) 25 24 21 24 30 26 26 28 
Underweight (<18.5kg/m2) 1 0 1 1 2 1 1 1 
Overweight (25.0 - 29.9 kg/m2) 49 46 48 47 38 36 37 37 
Obese I (30.0 - 34.9kg/m2) 15 18 21 18 18 19 20 19 
Obese II (≥ 35kg/m2) 3 4 3 3 5 8 8 7 
Missing 7 8 7 7 6 10 8 8 
Cigarette smoking status         
Never smoked 22 26 29 26 43 49 51 47 
Ex-smoker 64 63 60 63 42 41 39 41 
Current smoker 13 10 12 12 15 10 9 12 
Missing 0 0 0 0 0 0 0 0 
Cardiovascular disease         
No CVD b 53 61 65 58 55 60 62 58 
Doctor-diagnosed CVD b 47 39 35 42 45 40 37 41 
Missing 0 0 0 0 0 0 1 0 
Age at leaving fulltime education         
≥ 16 years 26 39 40 34 27 36 40 34 
<16 years 72 60 60 64 72 62 59 65 
Missing 2 2 0 1 2 2 0 1 
Occupational social class         
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Non-manual 47 50 53 50 51 60 60 57 
Manual 52 49 46 50 42 36 36 38 
Missing 1 0 0 1 6 3 4 5 
Equivalised household income         
Highest quintile c 6 9 8 8 4 5 6 5 
2nd highest quintile 12 11 10 11 8 8 7 8 
3rd quintile 22 19 23 21 18 18 20 19 
2nd lowest quintile 27 24 29 27 36 22 37 31 
Lowest quintile 19 21 13 18 17 28 12 20 
missing 14 15 16 15 17 20 18 18 
Vital status at end of follow-up period        
Died 54 19 15 32 47 13 10 25 
Survived 46 81 85 68 53 87 90 75 
 
a WHO criteria for anaemia: haemoglobin <13.0g/dl for men, <12.0g/dl for women 
b CVD: Cardiovascular conditions including stroke, myocardial infarction, angina, dysrhythmia, heart murmur 
or other heart condition 
c Equivalised household income (taking account of the number and age of householders); quintiles based on 
the whole core survey sample (all ages) for each survey year. 
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Table 3 Adjusted hazard ratios for mortality associated with bands of 
haemoglobin level 
 
adjusted for age only 
adjusted for multiple 
factors 1 
  
Hazard 
ratio 
Confidence 
interval 
Hazard 
ratio 
Confidence 
interval 
Men 
      Haemoglobin:  
      more than 1g/dl below WHO limit a 2.19 1.66 2.90 1.87 1.39 2.53 
0.1 - 1 g/dl below WHO limit a 1.64 1.31 2.06 1.56 1.24 1.96 
0 - 0.9 g/dl above WHO limit a 1.08 0.88 1.34 1.08 0.88 1.34 
1 - 1.9 g/dl above WHO limit a 1 
  
1 
  2 - 2.9 g/dl above WHO limit a 0.86 0.70 1.06 0.90 0.73 1.11 
3 g/dl or more above WHO limit a 1.35 1.04 1.74 1.32 1.02 1.70 
Women 
      Haemoglobin:  
      more than 1g/dl below WHO limit a 1.61 1.08 2.41 1.32 0.91 1.92 
0.1 - 1 g/dl below WHO limit a 1.30 0.99 1.72 1.22 0.93 1.61 
0 - 0.9 g/dl above WHO limit a 1.05 0.86 1.29 1.04 0.85 1.28 
1 - 1.9 g/dl above WHO limit a 1 
  
1 
  2 - 2.9 g/dl above WHO limit a 1.02 0.84 1.23 1.02 0.84 1.24 
3 g/dl or more above WHO lim a it 1.37 0.99 1.91 1.30 0.95 1.79 
 
Adjusted for age-group, age at leaving full-time education, smoking status, limiting or non-limiting 
longstanding illness, and BMI category. 
a WHO criteria for anaemia: haemoglobin <13.0g/dl for men, <12.0g/dl for women 
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Figure 1. Mortality by haemoglobin level. Adjusted hazard ratios for mortality by 
haemoglobin quintiles for men (A) and women (B); and by 1g/dl band for men (C) and 
women (D). 
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Figure 2. Survival by haemoglobin level. Adjusted Kaplan-Meier curves by 
haemoglobin level for men (top) and women (bottom).  
 
 
